Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8770823 | The Journal of Urology | 2018 | 28 Pages |
Abstract
The purified protein derivative skin test prior to bacillus Calmette-Guérin treatment enhances the therapeutic effects of this treatment and potentially results in a higher incidence of major bacillus Calmette-Guérin related side effects. Combination therapy with bacillus Calmette-Guérin using the purified protein derivative skin test may improve the oncologic outcomes of that therapy.
Keywords
RFSBCGPPDCISNMIBCTURBTAdjuvantsBacillus Calmette-GuérinPFsskin testsAdverse effectsImmunologicprogression-free survivalRecurrence-free survivaltransurethral bladder tumor resectionNonmuscle invasive bladder cancerUrinary bladder neoplasmsLower urinary tract symptomspurified protein derivativeLUTSBCG vaccineCarcinoma in situ
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Naoya Niwa, Eiji Kikuchi, Kazuhiro Matsumoto, Takeo Kosaka, Ryuichi Mizuno, Mototsugu Oya,